Financial updates
Pharming Group reports financial results for full year 2020
Pharming Group N.V. presents its preliminary (unaudited) financial report for the full year ended 31 December 2020.
''We are pleased to announce continued growth during 2020, especially, having achieved a net sales level that requires the payment of the final $25 million milestone to Bausch Health Inc. significantly earlier than originally anticipated''
- Sijmen de Vries - CEO